FOLFOX-4 REGIMEN AS ADJUVANT TREATMENT OF RADICALLY RESECATED GASTRIC CANCER PATIENTS

被引：0
|
作者：
Lucia, Cannella [1 ]
Alfonso, De Stefano [1 ]
Antonella, Prudente [1 ]
Carolina, Cimminiello [1 ]
Elide, Matano [1 ]
Roberto, Bianco [1 ]
Chiara, Carlomagno [1 ]
Anna, Crispo [1 ]
Sabino, De Placido [1 ]
机构：
[1] Univ Naples Federico 2, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients
    Yeh, Yung-Sung
    Tsai, Hsiang-Lin
    Ma, Cheng-Jen
    Wu, Deng-Chyang
    Lu, Chien-Yu
    Wu, I-Chen
    Hou, Ming-Feng
    Wang, Jaw-Yuan
    CHEMOTHERAPY, 2012, 58 (05) : 411 - 418
  • [22] Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy
    Mirakhorli, Mojgan
    Rahman, Sabariah Abdul
    Abdullah, Syahrilnizam
    Vakili, Masoud
    Rozafzon, Reza
    Khoshzaban, Ahad
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 613 - 617
  • [23] Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric Cancer
    Kim, Young Saing
    Hong, Junshik
    Sym, Sun Jin
    Park, Se Hoon
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2010, 42 (01): : 24 - 29
  • [24] Oxaliplatin, 5-fluorouracil, and leuvocorin and (FOLFOX-4) combination chemotherapy as salvage treatment in pretreated patients with advanced gastric cancer (AGC)
    Kim, Y.
    Park, S.
    Park, J.
    Cho, E.
    Shin, D.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] The effect of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy.
    Karaca, Halit
    Berk, Veli
    Inanc, Mevlude
    Dikilitas, Mustafa
    Ozkan, Metin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy
    Karaca, Halit
    Bozkurt, Oktay
    Ozaslan, Ersin
    Baldane, Suleyman
    Berk, Veli
    Inanc, Mevlude
    Duran, Ayse Ocak
    Dikilitas, Mustafa
    Er, Ozlem
    Ozkan, Metin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3641 - 3644
  • [27] A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin
    He, Shengli
    Shen, Jie
    Sun, Xianjun
    Liu, Luming
    Dong, Jingcheng
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (04) : 243 - 247
  • [28] EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE
    Ducournau, P.
    Latimer, N.
    Sabate, E.
    Walzer, S.
    VALUE IN HEALTH, 2008, 11 (06) : A471 - A472
  • [29] Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
    Pierpaolo Correale
    Fabio Fulfaro
    Stefania Marsili
    Giuseppe Cicero
    Eugenia Bajardi
    Chiara Intrivici
    Giuseppe Vuolo
    Antonio Ferdinando Carli
    Michele Caraglia
    Salvatore Del Prete
    Ettore Greco
    Nicola Gebbia
    Guido Francini
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 563 - 568
  • [30] Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy
    Han, Song-Hee
    Kim, Jin Won
    Kim, Milim
    Kim, Jee Hyun
    Lee, Keun-Wook
    Kim, Bo-Hyung
    Oh, Heung-Kwon
    Kim, Duck-Woo
    Kang, Sung-Bum
    Kim, Hyunchul
    Shin, Eun
    ONCOLOGY LETTERS, 2019, 17 (06) : 5572 - 5580
12345